Skip to main content
SpringerLink
Log in

Ipilimumab/pembrolizumab

Type 1 diabetes mellitus and diabetic ketoacidosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Aleksova J, et al. Treating type 1 diabetes with glucocorticosteroids: A case report of PD-1 receptor inhibition induced type 1 diabetes. Clinical Endocrinology 84 (Suppl. 1): 5 abstr. 46, 03 Mar 2016. Available from: URL: http://doi.org/10.1111/cen.13010 [abstract] - Australia

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ipilimumab/pembrolizumab. Reactions Weekly 1607, 237 (2016). https://doi.org/10.1007/s40278-016-18811-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-18811-x

Search

Navigation